Browse > Article
http://dx.doi.org/10.4163/jnh.2013.46.4.324

Effect of green tea intake on blood lipids, platelet aggregation, antioxidant and liver parameters in Jeju volunteer diving woman  

Kim, Mi-Sook (Department Foods & Nutrition, Jeju National University)
Kang, Min-Sook (Nutrition Service Team, Jeju National University Hospital)
Ryou, Sung-Hee (Department Foods & Nutrition, Jeju National University)
Moon, Young-In (Jeju Agricultural Development and Technology Extention Center)
Kang, Jung-Sook (Department Foods & Nutrition, Jeju National University)
Publication Information
Journal of Nutrition and Health / v.46, no.4, 2013 , pp. 324-331 More about this Journal
Abstract
We investigated dietary effects of green tea powder (GTP) on plasma lipids, platelet aggregation, hemolysis, plasma TBARS, and liver enzymes. Thirty one volunteer diving women living on Jeju island consumed 4 g green tea powder daily for a period of four weeks and data for the study subjects were analyzed on the basis of diagnostic criteria for blood pressure (BP)(${\geq}$ 140/90 mmHg), plasma total cholesterol (TC)(${\geq}$ 200 mg/dL), and triglyceride (TG)(${\geq}$ 150mg/dL). Subjects with high BP had significantly higher TC and TG than those with normal BP. Subjects with higher TC had higher TG, and those with higher TG had lower HDL cholesterol. Platelet aggregation in the initial slope was significantly higher in subjects with normal BP, normal TC, or normal TG than their counterparts in high BP, TC, and TG. HDL cholesterol after GTP intake increased only in subject groups with normal BP, normal TC, or normal TG, and plasma TG after GTP intake decreased only in groups with higher BP, higher TG, or higher TC. Plasma TC and TG in subjects with normal BP increased after GTP intake. GTP intake caused a decrease in the initial slope of platelet aggregation in all subject groups with little effect on maximum aggregation. Total bilirubin showed a significant increase and GOT increased in all subject groups after GTP intake. Beneficial effects of short term intake of green tea powder might differ depending on the subject conditions in terms of blood pressure, plasma lipids, and other cardiovascular conditions. However, with the hypolipidemic, antithrombotic, and antioxidant actions of its bioactive flavonoids, long term usage of GTP or brewed green tea may provide preventive effects against cardiovascular disease.
Keywords
green tea powder; hypolipidemic; antithrombotic; antioxidant; women;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Shen CL, Smith BJ, Lo DF, Chyu MC, Dunn DM, Chen CH, Kwun IS. Dietary polyphenols and mechanisms of osteoarthritis. J Nutr Biochem 2012; 23(11): 1367-1377   DOI
2 Shin MK. Green tea science. Korean J Diet Cult 1994; 9(4): 433-445
3 Trevisanato SI, Kim YI. Tea and health. Nutr Rev 2000; 58(1): 1-10
4 Fuhrman BJ, Pfeiffer RM, Wu AH, Xu X, Keefer LK, Veenstra TD, Ziegler RG. Green tea intake is associated with urinary estrogen profiles in Japanese-American women. Nutr J 2013; 12: 25   DOI
5 Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr 2008; 138(8): 1548S-1553S   DOI
6 Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 2002; 83(1-2): 109-116   DOI
7 Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 2005; 13(7): 1195- 1204   DOI
8 Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishikawa H, Ogawa S, Katsurada M. Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 1996; 6(3): 128-133   DOI
9 Elisaf M, Karabina SA, Bairaktari E, Goudevenos JA, Siamopoulos KC, Tselepis AD. Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia. Platelets 1999; 10 (2-3): 124-131   DOI
10 Sugatani J, Fukazawa N, Ujihara K, Yoshinari K, Abe I, Noguchi H, Miwa M. Tea polyphenols inhibit acetyl-CoA:1-alkyl-snglycero- 3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Int Arch Allergy Immunol 2004; 134(1): 17-28   DOI
11 Deana R, Turetta L, Donella-Deana A, Dona M, Brunati AM, De Michiel L, Garbisa S. Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists. Thromb Haemost 2003; 89(5): 866-874
12 Hsu SP, Wu MS, Yang CC, Huang KC, Liou SY, Hsu SM, Chien CT. Chronic green tea extract supplementation reduces hemodialysis- enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am J Clin Nutr 2007; 86(5): 1539-1547   DOI
13 Saffari Y, Sadrzadeh SM. Green tea metabolite EGCG protects membranes against oxidative damage in vitro. Life Sci 2004; 74 (12): 1513-1518   DOI
14 Biswas S, Bhattacharyya J, Dutta AG. Oxidant induced injury of erythrocyte-role of green tea leaf and ascorbic acid. Mol Cell Biochem 2005; 276(1-2): 205-210   DOI
15 Hirano-Ohmori R, Takahashi R, Momiyama Y, Taniguchi H, Yonemura A, Tamai S, Umegaki K, Nakamura H, Kondo K, Ohsuzu F. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. J Am Coll Nutr 2005; 24(5): 342-346   DOI
16 Sakong J. Diving patterns and diving related disease of diving fishermen in Korea. Korean J Prev Med 1998; 31(1): 139-156
17 Draper HH, Csallany AS. A simplified hemolysis test for vitamin E deficiency. J Nutr 1969; 98(4): 390-394   DOI
18 Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003; 14(6): 326-332   DOI
19 Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15(2): 212-216   DOI
20 Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol 2009; 53(3): 244- 253   DOI
21 de Freitas EV, BrandAo AA, Pozzan R, MagalhAes ME, Fonseca F, Pizzi O, Campana E, Brandao AP. Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly. Arch Gerontol Geriatr 2011; 52(2): 217-222   DOI
22 Kang JA, Chae IS, Song YB, Kang JS. Effects of green tea on weight gain, plasma and liver lipids and lipid peroxidation in pair fed rats. Korean J Nutr 2008; 41(7): 602-611
23 Bursill CA, Abbey M, Roach PD. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007; 193(1): 86-93   DOI
24 Han SG, Kang MS, Ryou SH, Hwang SW, Kang JS. Effect of prickly pear cactus (Opuntina ficus-indica) intake on blood lipids, platelet aggregation, antioxidant and liver parameters in volunteer diving woman. Korean J Nutr 2012; 45(5): 462-469   DOI
25 von Lewinski F, Riggert J, Paulus W. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis? J Stroke Cerebrovasc Dis 2009; 18(2): 111-115   DOI
26 Lukasik M, Dworacki G, Michalak S, Kufel-Grabowska J, Golanski J, Watala C, Kozubski W. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. Thromb Res 2011; 128(5): e73- e80   DOI
27 Lee YJ, Chung HY, Kwak HK, Yoon S. The effects of A. senticosus supplementation on serum lipid profiles, biomarkers of oxidative stress, and lymphocyte DNA damage in postmenopausal women. Biochem Biophys Res Commun 2008; 375(1): 44-48   DOI
28 Chello M, Spadaccio C, Patti G, Lusini M, Barbato R, Goffredo C, Di Sciascio G, Covino E. Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation. Atherosclerosis 2008; 197(2): 588-595   DOI